Delivery Order SPE2DB22D3301-SPE2DB24FX9DC
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,178.76 firm fixed-price delivery order is for the supply of 4,563,155,034 units of Nitrofurantoin Mono-MCR 100mg, a medication used to treat infections. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050 firm fixed-price delivery order is for the supply of 4,566,994,723 units of the generic drug Nitrofurantoin Mono-MCR 100 mg, with a period of performance through January 22, 2025. The contract is not designated as a set-aside and represents a discrete delivery order under a larger Indefinite Delivery...
- This federal contract award, valued at $2,760.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product, with a completion date of March 14, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,962.11 firm fixed-price delivery order is for the supply of 4,566,995,841 units of NITROFURANTOIN MONO-MCR 100 MG 1000S, a generic pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $8,492.31 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product, with a completion date of November 21, 2023. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The $1,153.56 firm-fixed-price delivery order is for the supply of Nitrofurantoin, a prescription medication, with a performance period through August 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,566.76 firm-fixed-price delivery order is for the supply of the pharmaceutical drug Nitrofurantoin Mono-MCR 100 mg, with a period of performance through September 25, 2023. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award, valued at $5,270.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,106.37, is for the delivery of 4567670792 NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 25, 2025. It is not designated as a set-aside contract. Amerisourcebergen...
- This federal contract award, valued at $30,697.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,182,939 units of Nitrofurantoin Mono-MCR 100 mg medication to support federal healthcare programs. The award is a firm-fixed-price delivery order with a completion date of December 28, 2023. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX9DCDelivery Order
This federal contract award is a delivery order valued at $3,311.76 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Nitrofurantoin Mono-MCR 100 mg tablets, a generic medication used to treat urinary tract infections. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/22/24 |